Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
Iddo Magen, Regina Ostritsky, Franziska Richter, Chunni Zhu, Sheila M. Fleming, Vincent Lemesre, Alistair J. Stewart, Bruce H. Morimoto, Illana Gozes*, Marie Françoise Chesselet
Research output: Contribution to journal › Article › peer-review
43Scopus
citations
Fingerprint
Dive into the research topics of 'Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein'. Together they form a unique fingerprint.